Table 4.
Longitudinal reference standards used by CIMAC-CIDC
| Reference material | Description | Amount used | Frequency of testing | |
|---|---|---|---|---|
| CyTOF | BioLegend PBMCs | 1:1 mixture of dual-labeled activated and resting PBMC Veri-Cells | 200–350 vials (1 million cells per vial) | Spiked into every clinical sample at 10 % volume |
| Olink | Various | • Pooled plasma from healthy donors • Randox cytokine cocktail • Olink experimental controls |
Over 1,000 aliquots available | Used in every run |
| ELISA Grand Serology | Healthy Plasma Pools | • Healthy-donor plasma pools as negative control and titer calculations • Positive plasma pools from patients with reactivity to several antigens |
Over 300 mL of plasma available (3–15 µl per assay) | Used as appropriate |
| IHC/IF MIBI | CHTN Master TMA | Master Tissue MicroArray (TMA) containing normal, neoplastic, and tumor tissue | Sequential sections will be distributed by CHTN (four TMAs blocks) | Twice per year |
| WES | Coriell Institute HapMap Cell Line Pool | • Two pools of 10 HapMap cell lines containing different allele fractions. • Two cell lines as germline controls |
Cell-line pellets embedded into FFPE blocks, extracted DNA distributed to each site | Twice per year Used as analysis pipelines develop over time |
| Microbiome | Various | • Healthy donor fecal samples (RefA) • ZymoBIOMICS Microbial Community Standard (RefB) • DNA library of gut-relevant microbes of known abundance (RefC) |
• RefA: 60 ready-to-use aliquots from ~100 mg of material • RefB: commercially available |
Used to control biases and batch effects for extractions, library prep, and sequencing runs |
CHTN: Cooperative Human Tissue Network